Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 7.81

From 52W high−24.21%

Volume10.03M

Market capCNY 15.57B

P/E (TTM)12.8x

P/S (TTM)5.1x

Div yield3.82%

Key dataSep 18, 2026

Open

CNY 7.81

From 52W high

−24.21%

Volume

10.03M

Market cap

CNY 15.57B

ValuationView details →

P/E (Fwd)

29.1x

EV/EBITDA

7.5x

P/E (TTM)

12.8x

RSI (14)

42.5

MomentumView details →

1D Return

−1.97%

YTD Return

−3.92%

ValuationView details →

P/E (Fwd)

29.1x

P/E (TTM)

12.8x

EV/EBITDA

7.5x

EV/Sales

4.6x

P/S (TTM)

5.1x

P/B (TTM)

2.3x

ProfitabilityView details →

Gross Margin

70.86%

Net Margin

40.64%

EBITDA Margin

61.39%

ROE (TTM)

17.08%

ROA (TTM)

14.99%

Asset Turnover

0.38x

GrowthView details →

Revenue YoY

+47.04%

EPS YoY

+824.78%

FCF YoY

+310.17%

Revenue CAGR 3Y

+1.99%

EPS CAGR 3Y

−7.76%

EBITDA YoY

—

MomentumView details →

1D Return

−1.97%

YTD Return

−3.92%

1Y Return

−3.56%

RSI (14)

42.5

vs 50D SMA

−4.02%

vs 200D SMA

−8.59%

Capital & dividendView details →

Debt/Equity

0.06x

Current Ratio

4.84x

Quick Ratio

3.85x

Div Yield

3.82%

Div Rate

CNY 0.30

Div Growth 1Y

+20.00%

EarningsView details →

EPS (Actual)

CNY 0.09

EPS Surprise

50.02%

Beats (12Q)

1/12

Next Q EPS Est

CNY 0.08

Avg Surprise (4Q)

50.02%

Rev Surprise

−2.12%

Financials snapshotView financials →

Revenue (TTM)

3.04B

Net Income (TTM)

1.24B

Op. CF (TTM)

853.07M

Next earningsNov 3, 2026 →

Latest newsMore news →

Tonghua Dongbao announced its first-half 2026 results: net profit attributable to shareholders was 296 million yuan, up 37.32% year-on-year, with revenue of 1.553 billion yuan, up 11.13%.27d ago

Tonghua Dongbao subscribed to 1.62 million convertible bonds issued by Tebao Bio for 162 million yuan, which were fully allocated and will be listed on the Shanghai Stock Exchange on August 13, 2026.40d ago

Similar companies

Vigonvita Life Sciences Co., Ltd.02630.HK Metacare Co., Ltd.118000.KS 奥瑞德600666.SH Tdspharm464280.KQ Biogen Inc.BIIB BCWORLD PHARM. Co., Ltd.200780.KQ Find similar companies →

Latest newsMore news →

Tonghua Dongbao announced its first-half 2026 results: net profit attributable to shareholders was 296 million yuan, up 37.32% year-on-year, with revenue of 1.553 billion yuan, up 11.13%.27d ago Tonghua Dongbao subscribed to 1.62 million convertible bonds issued by Tebao Bio for 162 million yuan, which were fully allocated and will be listed on the Shanghai Stock Exchange on August 13, 2026.40d ago